Publications

Journal Article Epublish 5 citations
Electronic publication date
September 10, 2019

View on Pubmed.gov 31496759 | View on doi.org 10.2147/IDR.S20...

Prevalence, risk and genetic characteristics of drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.

Search for publications in this journal Infect Drug Resist

  • Li-Li Zhao

    Search for this expert
    1
  • Ming-Xiang Huang

    Search for this expert
    2
  • Tong-Yang Xiao

    Search for this expert
    1
  • Hai-Can Liu 1
  • Ma-Chao Li 1
  • Xiu-Qin Zhao

    Search for this expert
    1
  • Zhi-Guang Liu

    Search for this expert
    1
  • Yi Jiang

    Search for this expert
    1
  • Kang-Lin Wan

    Search for this expert
    1

Abstract

OBJECTIVES

To explore the prevalence, risk and genetic characteristics of drug-resistant tuberculosis (TB) from a tertiary care TB hospital in China.

PATIENTS AND METHODS

We carried out a retrospective study including isolates from 189 patients with pulmonary TB at Fuzhou Pulmonary Hospital. All isolates from these patients were subjected to drug susceptibility testing and genotyping. For drug-resistant isolates, DNA sequencing was used to investigate mutations in 12 loci, including , , , , , (nucleotides 388-1084 of rrs), , , , (nucleotides 1158-1674 of rrs), and .

RESULTS

Among 189 isolates, 28.6% were resistant to at least one of the seven anti-TB drugs, including isoniazid (INH), rifampin (RIF), streptomycin (STR), ethambutol (EMB), capreomycin (CAP), kanzmycin (KAN) and ofloxacin (OFX). The proportion of multidrug-resistant TB and extensively drug-resistant TB isolates was 9.5% and 1.1%, respectively. Patients in rural areas as well as previously treated patients showed a significantly increased risk of developing drug resistance. In addition, among these isolates, 111 (58.7%) were Beijing genotype strains, 84 (75.7%) of which belonged to modern Beijing sublineage. There was no association between genotype and drug resistance. The most common mutations were 315, 531 43, 306, 1401 and 94.

CONCLUSION

These findings provided additional information of drug-resistant TB in China. Previously treated patients and patients in rural areas should receive greater attention owing to their higher risk of developing drug resistance.

References

Microbes Infect. 2000 May;2(6):659-69

Front Biosci. 2004 Jan 01;9:975-94

J Clin Microbiol. 2005 Jun;43(6):2996-7

Chemotherapy. 2006;52(6):316-20

Cited by 5 citations (total)

Journal Article

Genetic diversity and transmission pattern of multidrug-resistant tuberculosis based on whole-genome sequencing in Wuhan, China.

Electronic publication date February 12, 2025

Search for publications in this journal Front Public Health

Liqing Wei [...] Qionghong Duan et al.

Background

Investigating the molecular epidemiological characteristics of multidrug-resistant tuberculosis (MDR-TB) in China's moderate-burden regions, such as Wuhan, is crucial for understanding...

Journal Article

Prevalence and Molecular Characteristics Based on Whole Genome Sequencing of Resistant to Four Anti-Tuberculosis Drugs from Southern Xinjiang, China.

Electronic publication date September 2, 2021

Search for publications in this journal Infect Drug Resist

Aiketaguli Anwaierjiang [...] Kanglin Wan et al.

OBJECTIVE

Drug-resistant tuberculosis is a major public health problem, especially in the southern region of Xinjiang, China; however, there is little...

Conflict of interest statement

The authors report no conflicts of interest in this work.

MeSH

Specialties